Auris Medical Holding Ltd has Encouraging Results Addressing the Unmet Needs of ATLL

Auris Medical Holding Ltd OligoPhoreTM Technology for ATLL
Auris Medical Holding Ltd. (EARS) is a company focusing on addressing unmet medical needs through RNA therapeutics for allergies, viral infection protection and inner ear therapeutics. The firm has published results from an in vivo study demonstrating significant inhibition of tumor growth.

The inhibition of tumor growth occurred by siRNA knock-down of . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.